Funded Startups in Pittsburgh
Disclosed round sizes in Pittsburgh skew heavily toward a single outlier: Peptilogics raised $78M on 2025-10-16, which sits well above the next-largest dis…
Disclosed round sizes in Pittsburgh skew heavily toward a single outlier: Peptilogics raised $78M on 2025-10-16, which sits well above the next-largest disclosed amounts in the list (e.g., Abridge $300M is the largest disclosed; next after that are in the $135M–$125M range from Skild AI $135M on 2025-06-13 and Gecko Robotics $125M on 2025-06-12). A second pattern is both temporal and sectoral: AI-related entries recur across multiple months (Abridge 2025-06-24 $300M; Skild AI 2025-06-13 $135M; Mapless AI 2024-02-08 $100K), while biotech is also repeatedly represented (Peptilogics 2025-10-16 $78M; Lipella Pharmaceuticals 2025-03-04 $4M; Novasenta 2024-02-05 $15M). Across 50 listed rows, rounds span 2023-11-02 (Vigilant Ops, $2M) through 2025-11-23 (PECA Labs, $3M), with several “Series Unknown” or undisclosed amounts concentrated in the mid-list (e.g., Lovelace on 2025-05-06 is undisclosed; iTruckr on 2025-03-06 is undisclosed).
Most recent rounds
50 shownRelated listings
Frequently asked
What stands out as the largest disclosed round in Pittsburgh, and how far ahead is it of the rest?
Abridge’s $300M round on 2025-06-24 is the largest disclosed amount in the list, with the next-largest disclosed entries notably lower—Skild AI at $135M (2025-06-13) and Gecko Robotics at $125M (2025-06-12).
Are there short time windows where funding is especially dense among Pittsburgh companies?
Yes. In early to mid-March 2024, several entries cluster on the same date (e.g., Efficient Computer $16M on 2024-03-07 and multiple undisclosed rounds on 2024-03-07: ESTAT Actuation and KEF Robotics). Another dense stretch appears in June 2025, where multiple large disclosures land within days (Abridge 2025-06-24 $300M; Skild AI 2025-06-13 $135M; Gecko Robotics 2025-06-12 $125M).
Which sectors recur most often in these 50 recent rows?
Artificial Intelligence appears repeatedly (Abridge 2025-06-24 $300M; Skild AI 2025-06-13 $135M; Mach9 2024-11-14 $12M; Mapless AI 2024-02-08 $100K; plus other AI-labeled entries like velo.ai and NOMA AI). Biotechnology also shows up across multiple rounds (Peptilogics 2025-10-16 $78M; Lipella Pharmaceuticals 2025-03-04 $4M; Mindstate Design Labs 2024-11-26 $13M; Novasenta 2024-02-05 $15M; among others).
How does stage labeling behave—are “Series Unknown” and undisclosed amounts common?
They appear frequently enough to affect comparisons. Examples include Lovelace (Seed, 2025-05-06, amount undisclosed) and iTruckr (2025-03-06, amount undisclosed), plus multiple “Series Unknown” labels such as PECA Labs (2025-11-23 $3M) and Mach9’s contrasting known stage as Seed on 2024-11-14 $12M.
Is any single company at the low end of disclosed funding clearly separated from other small disclosed rounds?
At the low end, Elizabeth Seton Center is disclosed at just $10K on 2025-04-04. Several other small disclosed rounds exist (e.g., Metafus $100K on 2025-09-20; NOMA AI $100K on 2024-08-01), but $10K is the only disclosed amount at that extreme in the list.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.